Remitogen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2001
0120012001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
The humanized monoclonal antibody Hu1D10 (Remitogen, Protein Design Labs, Fremont, CA) recognizes a polymorphic determinant of… (More)
Is this relevant?
2002
2002
Antibody-based approaches have become a novel treatment modality for lymphoma patients. Humanized 1D10 (Hu1D10; Remitogen) is… (More)
Is this relevant?
2002
2002
 
  • figure 1
Is this relevant?
2002
2002
  • Expert review of anticancer therapy
  • 2002
 
Is this relevant?